Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake
Amber L. Alhadeff, Laura E. Rupprecht, Matthew R. Hayes
Endocrinology (2011) Vol. 153, Iss. 2, pp. 647-658
Open Access | Times Cited: 414

Showing 26-50 of 414 citing articles:

Reverse-translational identification of a cerebellar satiation network
Aloysius Y. T. Low, Nitsan Goldstein, Jessica Gaunt, et al.
Nature (2021) Vol. 600, Iss. 7888, pp. 269-273
Open Access | Times Cited: 106
Acts of appetite: neural circuits governing the appetitive, consummatory, and terminating phases of feeding
Ivan C. Alcantara, Ana Pamela Miranda Tapia, Yeka Aponte, et al.
Nature Metabolism (2022) Vol. 4, Iss. 7, pp. 836-847
Closed Access | Times Cited: 82
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
Vicky Chuong, Mehdi Farokhnia, Sophia Khom, et al.
JCI Insight (2023) Vol. 8, Iss. 12
Open Access | Times Cited: 81
Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats
Cajsa Aranäs, Christian E. Edvardsson, Olesya T. Shevchouk, et al.
EBioMedicine (2023) Vol. 93, pp. 104642-104642
Open Access | Times Cited: 56
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
William Wang, Nora D. Volkow, Nathan A. Berger, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
Camille Lupiañez-Merly, Saam Dilmaghani, Kia Vosoughi, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 4, pp. 475-491
Closed Access | Times Cited: 18
Mechanisms of GLP-1 receptor agonist-induced weight loss: A review of central and peripheral pathways in appetite and energy regulation
Areesha Moiz, Kristian B. Filion, Michael A. Tsoukas, et al.
The American Journal of Medicine (2025)
Open Access | Times Cited: 2
Addiction science: Uncovering neurobiological complexity
Nora D. Volkow, Rubén Baler
Neuropharmacology (2013) Vol. 76, pp. 235-249
Open Access | Times Cited: 187
Incretin hormones and the satiation signal
Jens J. Holst
International Journal of Obesity (2013) Vol. 37, Iss. 9, pp. 1161-1168
Open Access | Times Cited: 176
GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents
Jianping Ye, Hao Zheng, Michael B. Mumphrey, et al.
AJP Regulatory Integrative and Comparative Physiology (2014) Vol. 306, Iss. 5, pp. R352-R362
Open Access | Times Cited: 171
Ghrelin Acts as an Interface between Physiological State and Phasic Dopamine Signaling
Jackson J. Cone, James E. McCutcheon, Mitchell F. Roitman
Journal of Neuroscience (2014) Vol. 34, Iss. 14, pp. 4905-4913
Open Access | Times Cited: 168
Glucagon-like peptide 1 and appetite
Megan J. Dailey, Timothy H. Moran
Trends in Endocrinology and Metabolism (2013) Vol. 24, Iss. 2, pp. 85-91
Open Access | Times Cited: 164
The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors
Elizabeth G. Mietlicki‐Baase, Pavel I. Ortinski, Laura E. Rupprecht, et al.
AJP Endocrinology and Metabolism (2013) Vol. 305, Iss. 11, pp. E1367-E1374
Open Access | Times Cited: 154
The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents
Emil Egecioglu, Pia Steensland, Ida Fredriksson, et al.
Psychoneuroendocrinology (2012) Vol. 38, Iss. 8, pp. 1259-1270
Open Access | Times Cited: 149
Hippocampal GLP-1 Receptors Influence Food Intake, Meal Size, and Effort-Based Responding for Food through Volume Transmission
Ted M. Hsu, Joel D. Hahn, Vaibhav Konanur, et al.
Neuropsychopharmacology (2014) Vol. 40, Iss. 2, pp. 327-337
Open Access | Times Cited: 147
Brain regulation of energy balance and body weight
Liangyou Rui
Reviews in Endocrine and Metabolic Disorders (2013) Vol. 14, Iss. 4, pp. 387-407
Open Access | Times Cited: 146
Gut Peptide GLP-1 and Its Analogue, Exendin-4, Decrease Alcohol Intake and Reward
Rozita H. Shirazi, Suzanne L. Dickson, Karolina P. Skibicka
PLoS ONE (2013) Vol. 8, Iss. 4, pp. e61965-e61965
Open Access | Times Cited: 143
Endogenous Glucagon-like Peptide-1 Suppresses High-Fat Food Intake by Reducing Synaptic Drive onto Mesolimbic Dopamine Neurons
Xue-Feng Wang, Jingjing Liu, Julia Xia, et al.
Cell Reports (2015) Vol. 12, Iss. 5, pp. 726-733
Open Access | Times Cited: 143
The central GLP-1: implications for food and drug reward
Karolina P. Skibicka
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 142
Activation of the GLP-1 Receptors in the Nucleus of the Solitary Tract Reduces Food Reward Behavior and Targets the Mesolimbic System
Jennifer E. Richard, Rozita H. Anderberg, Andreas Göteson, et al.
PLoS ONE (2015) Vol. 10, Iss. 3, pp. e0119034-e0119034
Open Access | Times Cited: 140
Feelings about food: the ventral tegmental area in food reward and emotional eating
Frank J. Meye, Roger A.H. Adan
Trends in Pharmacological Sciences (2013) Vol. 35, Iss. 1, pp. 31-40
Closed Access | Times Cited: 139
The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice
Emil Egecioglu, Jörgen A. Engel, Elisabet Jerlhag
PLoS ONE (2013) Vol. 8, Iss. 7, pp. e69010-e69010
Open Access | Times Cited: 126
Liraglutide and obesity: a review of the data so far
Ellen E. Ladenheim
Drug Design Development and Therapy (2015), pp. 1867-1867
Open Access | Times Cited: 125
Glucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes
Giovanna Muscogiuri, Ralph A. DeFronzo, Amalia Gastaldelli, et al.
Trends in Endocrinology and Metabolism (2016) Vol. 28, Iss. 2, pp. 88-103
Closed Access | Times Cited: 119
Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance
David J. Reiner, Elizabeth G. Mietlicki‐Baase, Lauren E. McGrath, et al.
Journal of Neuroscience (2016) Vol. 36, Iss. 12, pp. 3531-3540
Open Access | Times Cited: 116

Scroll to top